Jefferies Group LLC Esperion Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $969,999 - $1.44 Million	-50,000 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$25.12 - $36.89 $1.26 Million - $1.84 Million	50,000 New	50,000 $1.4 Million
Q1 2021 May 14, 2021	BUY	$25.12 - $36.89 $813,888 - $1.2 Million	32,400 Added 184.09%	50,000 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $705,760 - $921,008	17,600 New	17,600 $819,000
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $554,850 - $886,650	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $101,850 - $128,524	2,500 Added 20.0%	15,000 $666,000
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $452,500 - $955,000	12,500 New	12,500 $490,000

215

129M

1.78M

1.27M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $105M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.